Biomedical subjects
Publications and source records attributed to D Kupecz.
In 2000, more than 100 new drugs and devices were approved for use in the United States. Many drugs were reformulated to provide new uses, more effective dosing, or improved costs. In an effort to ensure safe prescribing practices, the Food and Drug Administration has increased drug and device monitoring and services available to clinicians.
Explore the source record for details and available documents.
Throughout 1999, the Food and Drug Administration approved several new drugs and medical devices. The agency also took an active role in defining public policies regarding pharmacologic issues for the American consumer. This article provides an overview of these topics.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Recent legislative reforms have allowed the Food and Drug Administration (FDA) to reduce the average approval process for new drugs from 30 to 15 months. Advances in technologic support have made access to the FDA widely available. This article reviews 14 recently approved drugs used in primary care along with clinical background and prescribing guidelines. Information on accessing FDA resources through the use of the Internet is also included.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Cigarette smoking remains the single most preventable cause of death in the United States. Nurses can be instrumental in assisting patients in quitting. A prospective quasi-experimental design was employed to investigate the differences in quit rates, adverse drug reactions, time to relapse, and secondary factors that contribute to smoking cessation in two groups of patients who attended a group program and used either a nicotine patch or nicotine gum. Although there were no significant differences in quit rates at one year, the patch group showed a significant increase in short-term quit rates and a decrease in adverse reactions as well as a longer time to relapse. Older patients demonstrated a longer time to relapse while a high degree of nicotine dependency was correlated with a shorter time to relapse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.